APL is characterized by the promyelocytic leukemia (PML), retinoic acid receptor alpha (RARα) fusion gene, which causes a maturation arrest at the promyelocyte stage, while AML more broadly is a heterogeneous group of myeloid malignancies defined by differentiation blocks at various developmental stages. Here, RARA is linked to leukemia.